Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 214,802,848
  • Shares Outstanding, K 1,738,872
  • Annual Sales, $ 41,950 M
  • Annual Income, $ 13,402 M
  • EBIT $ 9,438 M
  • EBITDA $ 12,656 M
  • 60-Month Beta 0.72
  • Price/Sales 4.92
  • Price/Cash Flow 18.99
  • Price/Book 4.24

Options Overview Details

View History
  • Implied Volatility 25.34% (-0.08%)
  • Historical Volatility 16.04%
  • IV Percentile 80%
  • IV Rank 34.07%
  • IV High 42.50% on 04/07/25
  • IV Low 16.47% on 01/24/25
  • Expected Move (DTE 7) 4.32 (3.52%)
  • Put/Call Vol Ratio 0.92
  • Today's Volume 9,541
  • Volume Avg (30-Day) 11,825
  • Put/Call OI Ratio 0.95
  • Today's Open Interest 205,072
  • Open Int (30-Day) 200,078
  • Expected Range 118.35 to 126.99

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.50
  • Number of Estimates 9
  • High Estimate 1.51
  • Low Estimate 1.49
  • Prior Year 1.34
  • Growth Rate Est. (year over year) +11.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
121.84 +0.58%
on 01/16/26
129.46 -5.33%
on 01/06/26
-4.31 (-3.40%)
since 12/16/25
3-Month
120.70 +1.53%
on 12/10/25
132.02 -7.18%
on 11/18/25
-5.08 (-3.98%)
since 10/16/25
52-Week
113.39 +8.08%
on 01/17/25
141.23 -13.23%
on 03/04/25
+8.64 (+7.58%)
since 01/16/25

Most Recent Stories

More News
1 Healthcare Stock to Consider Right Now and 2 We Find Risky

1 Healthcare Stock to Consider Right Now and 2 We Find Risky

TXG : 20.53 (-3.16%)
ABT : 122.61 (-0.74%)
OCUL : 11.80 (+4.61%)
Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report

Vertex Pharmaceuticals is scheduled to post its fourth-quarter results soon, and analysts project a double-digit earnings growth

ABT : 122.61 (-0.74%)
XLV : 156.33 (-0.40%)
$SPX : 6,946.99 (+0.04%)
VRTX : 443.75 (+1.10%)
Zimmer Biomet’s Q3 2025 Earnings: What to Expect

Zimmer Biomet is poised to report its fourth-quarter results in the near future, and Wall Street anticipates a measured, single-digit increase in earnings.

ZBH : 87.81 (-1.06%)
ABT : 122.61 (-0.74%)
XLV : 156.33 (-0.40%)
$SPX : 6,946.99 (+0.04%)
1 S&P 500 Stock to Consider Right Now and 2 We Turn Down

1 S&P 500 Stock to Consider Right Now and 2 We Turn Down

ABT : 122.61 (-0.74%)
ALGN : 172.75 (+0.75%)
IQV : 239.38 (-0.79%)
Earnings Preview: What To Expect From Molina Healthcare's Report

Molina Healthcare is expected to unveil its fourth-quarter results next month, and analysts expect a double-digit decrease in earnings.

ABT : 122.61 (-0.74%)
XLV : 156.33 (-0.40%)
$SPX : 6,946.99 (+0.04%)
MOH : 191.08 (-1.37%)
Abbott hosts conference call for fourth-quarter earnings

ABBOTT PARK, Ill. , Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter 2025 financial results on Thursday, Jan. 22, before the market opens.

ABT : 122.61 (-0.74%)
Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions

ABBOTT PARK, Ill. , Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a leading healthcare company, today unveiled  Libre Assist , 1 a groundbreaking feature within the Libre app 5 designed...

ABT : 122.61 (-0.74%)
What You Need To Know Ahead of Quest Diagnostics' Earnings Release

Quest Diagnostics is expected to unveil its fourth-quarter results soon, and analysts expect a single-digit growth in earnings.

ABT : 122.61 (-0.74%)
XLV : 156.33 (-0.40%)
DGX : 190.56 (+0.16%)
$SPX : 6,946.99 (+0.04%)
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings?

Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings?

ABT : 122.61 (-0.74%)
What You Need to Know Ahead of Abbott Laboratories' Earnings Release

Abbott Laboratories is expected to release its fiscal fourth-quarter earnings soon, and analysts project a low double-digit profit growth.

ABT : 122.61 (-0.74%)
XLV : 156.33 (-0.40%)
$SPX : 6,946.99 (+0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 125.72
2nd Resistance Point 125.07
1st Resistance Point 124.30
Last Price 122.61
1st Support Level 122.88
2nd Support Level 122.23
3rd Support Level 121.46

See More

52-Week High 141.23
Fibonacci 61.8% 130.60
Fibonacci 50% 127.31
Fibonacci 38.2% 124.02
Last Price 122.61
52-Week Low 113.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar